Prevalence of antibodies to hepatitis E in two rural Egyptian communities.

Authors:
  • MAM Abdel-Hamid
    M Abdel-Hamid
  • RPR H Purcell
    R H Purcell
  • MSM H Shehata
    M H Shehata
  • FAF Abdel-Aziz
    F Abdel-Aziz
  • NMN Mikhail
    N Mikhail
  • HSH el Sebai
    H el Sebai
  • MNM Nafeh
    M Nafeh
  • MHM Habib
    M Habib
  • RAR R Arthur
    R R Arthur
  • SES U Emerson
    S U Emerson
  • GSG T Strickland
    G T Strickland

Abstract
A population-based serosurvey in two rural Egyptian communities was used to assess age-specific prevalence of antibody to hepatitis E virus (anti-HEV). One community is in the Nile Delta (11,182 inhabitants; 3,997 participants) and the other in Upper Egypt (10,970 inhabitants; 6,029 participants). Samples were tested for anti-HEV with a commercial enzyme-linked immunoassay (ELISA) based on antigens derived from open reading frame (ORF)2 and ORF3. Although there was a clear difference in sensitivity among the lots of the commercial test used, it was still possible to determine the seroprevalence. The seroprevalence of anti-HEV exceeded 60% in the first decade of life, peaked at 76% in the second decade and remained above 60% until the eighth decade. Prevalence of this magnitude is among the highest reported in the world, with an age-specific pattern more similar to hyperendemic hepatitis A virus transmission than generally described. Lot-to-lot variation in the sensitivity of the commercial ELISA kit highlights a problem when comparing seroepidemiologic studies of different populations.